Amplify YieldShares Oil Hedged MLP Income ETF (AMLX) Social Stream
AMYLYX PHARMACEUTICALS INC (AMLX) Price Targets From Analysts
Use the tables below to see what analysts covering AMYLYX PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-01 | 2 | $50 | $35 | $42.5 | $16.22 | 162.02% |
| 2022-04-21 | 3 | $35 | $31 | $33 | $16.22 | 103.45% |
| 2022-05-13 | 5 | $35 | $10 | $25.333 | $16.22 | 56.18% |
| 2022-05-25 | 5 | $35 | $10 | $24.25 | $16.22 | 49.51% |
| 2022-06-14 | 5 | $35 | $10 | $27.25 | $16.22 | 68% |
| 2022-08-11 | 5 | $37 | $10 | $28.25 | $16.22 | 74.17% |
| 2022-10-02 | 5 | $50 | $35 | $43.25 | $16.22 | 166.65% |
| 2022-10-13 | 5 | $50 | $35 | $43.75 | $16.22 | 169.73% |
| 2022-11-11 | 5 | $50 | $40 | $47.5 | $16.22 | 192.85% |
| 2023-01-26 | 4 | $50 | $40 | $48 | $16.22 | 195.93% |
| 2023-03-14 | 5 | $50 | $40 | $48 | $16.22 | 195.93% |
| 2023-05-12 | 6 | $52 | $40 | $48.666 | $16.22 | 200.04% |
| 2023-05-30 | 6 | $50 | $40 | $48.333 | $16.22 | 197.98% |
| 2023-06-06 | 6 | $50 | $40 | $47.833 | $16.22 | 194.9% |
| 2023-06-26 | 6 | $50 | $40 | $47.5 | $16.22 | 192.85% |
| 2023-07-24 | 6 | $50 | $47 | $49 | $16.22 | 202.1% |
| 2023-10-08 | 6 | $50 | $47 | $48.166 | $16.22 | 196.95% |
| 2023-11-09 | 6 | $50 | $46 | $47.833 | $16.22 | 194.9% |
| 2023-11-10 | 7 | $48 | $27 | $40.833 | $16.22 | 151.74% |
| 2023-12-22 | 7 | $48 | $27 | $40.142 | $16.22 | 147.48% |
| 2023-12-29 | 7 | $48 | $27 | $37.428 | $16.22 | 130.75% |
| NA | 2 | $NA | $NA | $NA | $16.22 | NA% |
The Trend in the Analyst Price Target
Over the past 49 days, AMLX's average price target has gone down $4.91.
Over the past 49 weeks, AMLX's average upside potential has been 139.06%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-06-26 | 6 | 50 | 40 | 47.500 | 22.42 | 111.86% |
| 2023-07-27 | 6 | 50 | 47 | 48.166 | 22.26 | 116.38% |
| 2023-10-19 | 6 | 50 | 46 | 47.833 | 16.55 | 189.02% |
| 2023-11-10 | 7 | 48 | 27 | 40.833 | 12.48 | 227.19% |
| 2023-12-18 | 7 | 48 | 27 | 40.142 | 14.19 | 182.89% |
AMLX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 7 | 0 | 0 | 0 | 0 | 7 |
The Trend in the Broker Recommendations
Over the past 48 weeks, AMLX's average broker recommendation rating improved by 0.4.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, AMYLYX PHARMACEUTICALS INC's upside potential (average analyst target price relative to current price) is greater than 2322.07% of them.
- In terms of how AMYLYX PHARMACEUTICALS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 629.61% of that group.
- In terms of how AMYLYX PHARMACEUTICALS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -1050.34% of that group.
- AMLX has a higher average analyst price target than 1721.14% of Pharmaceutical Products stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to AMYLYX PHARMACEUTICALS INC are BHVN, GPCR, and PASG.
View All Top Stocks by Price Target
Is AMLX a Buy, Hold or Sell? See the POWR Ratings now!